Drug stocks are the new safe bet in a shaky market
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B
Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...